Veterinary Medicines

LINCOMYCIN-SPECTINOMYCIN 5/10, injekcinis tirpalas galvijams, kiaulėms, avims

Authorised
  • SPECTINOMYCIN HYDROCHLORIDE
  • Lincomycin hydrochloride
Download as PDF

Product identification

Medicine name:
LINCOMYCIN-SPECTINOMYCIN 5/10, injekcinis tirpalas galvijams, kiaulėms, avims
Active substance:
  • SPECTINOMYCIN HYDROCHLORIDE
  • Lincomycin hydrochloride
Target species:
  • Pig
  • Cattle (calf)
  • Sheep
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • SPECTINOMYCIN HYDROCHLORIDE
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Lincomycin hydrochloride
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        21
        day
    • Cattle (calf)
      • Meat and offal
        21
        day
    • Sheep
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Alfasan International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan International B.V.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/98/0760/001
Date of authorisation status change:

Documents

RV0760.pdf

Lithuanian (PDF)
Published on: 21/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."